Renalytix AI—developer of artificial intelligence ("AI") decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. incorporated in March 2018 as a subsidiary of EKF Diagnostics Holdings (AIM-EKF). Total fundraising in the range £21 - 25 m. Mkt cap - c. £67.5- £71.0m. Due 2 Nov.
Finncap—proposed acquisition of M&A adviser Cavendish Corporate Finance and AIM admission. Offer TBA
Kropz PLC—an emerging plant nutrient ....
01 Nov 2018
Small Cap Feast
Integumen (SKIN:LON), 0 | Safeland (SAF:LON), 0 | Ilika plc (IKA:LON), 28.0 | Nexus Infrastructure Plc (NEXS:LON), 70.0 | Destiny Pharma Plc (DEST:LON), 19.2 | MTI Wireless Edge Ltd (MWE:LON), 43.0 | Mpac Group PLC (MPAC:LON), 430 | AFC Energy plc (AFGYF:OTC), 0 | NetScientific plc (NSCI:LON), 63.0
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Small Cap Feast
Integumen (SKIN:LON), 0 | Safeland (SAF:LON), 0 | Ilika plc (IKA:LON), 28.0 | Nexus Infrastructure Plc (NEXS:LON), 70.0 | Destiny Pharma Plc (DEST:LON), 19.2 | MTI Wireless Edge Ltd (MWE:LON), 43.0 | Mpac Group PLC (MPAC:LON), 430 | AFC Energy plc (AFGYF:OTC), 0 | NetScientific plc (NSCI:LON), 63.0
- Published:
01 Nov 2018 -
Author:
Derren Nathan - Pages:
Renalytix AI—developer of artificial intelligence ("AI") decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. incorporated in March 2018 as a subsidiary of EKF Diagnostics Holdings (AIM-EKF). Total fundraising in the range £21 - 25 m. Mkt cap - c. £67.5- £71.0m. Due 2 Nov.
Finncap—proposed acquisition of M&A adviser Cavendish Corporate Finance and AIM admission. Offer TBA
Kropz PLC—an emerging plant nutrient ....